These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35906595)

  • 1. Healthcare utilization for somatic conditions among Swedish patients in opioid substitution treatment, with and without on-site primary healthcare.
    Vikbladh T; Troberg K; Håkansson A; Dahlman D
    BMC Health Serv Res; 2022 Jul; 22(1):971. PubMed ID: 35906595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare Contacts Regarding Circulatory Conditions among Swedish Patients in Opioid Substitution Treatment, with and without On-Site Primary Healthcare.
    Bäckström E; Troberg K; Håkansson A; Dahlman D
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33925318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare seeking among Swedish patients in opioid substitution treatment - a mixed methods study on barriers and facilitators.
    Troberg K; Lundqvist K; Hansson H; Håkansson A; Dahlman D
    Subst Abuse Treat Prev Policy; 2022 Feb; 17(1):8. PubMed ID: 35123518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceived healthcare stigma among patients in opioid substitution treatment: a qualitative study.
    Garpenhag L; Dahlman D
    Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):81. PubMed ID: 34702338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Rated Physical Health and Unmet Healthcare Needs among Swedish Patients in Opioid Substitution Treatment.
    Troberg K; Håkansson A; Dahlman D
    J Addict; 2019; 2019():7942145. PubMed ID: 31139491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid substitution therapy clients' preferences for targeted versus general primary health-care outlets.
    Islam MM; Topp L; Conigrave KM; Day CA
    Drug Alcohol Rev; 2013 Mar; 32(2):211-4. PubMed ID: 22925410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in opioid-related deaths following increased access to opioid substitution treatment.
    Andersson L; Håkansson A; Berge J; Johnson B
    Subst Abuse Treat Prev Policy; 2021 Feb; 16(1):15. PubMed ID: 33568184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Literacy among Swedish Patients in Opioid Substitution Treatment: A Mixed-Methods Study.
    Dahlman D; Ekefäll M; Garpenhag L
    Drug Alcohol Depend; 2020 Sep; 214():108186. PubMed ID: 32721789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.
    Richert T; Johnson B
    Harm Reduct J; 2015 Feb; 12():1. PubMed ID: 25889208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England.
    Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalfe C; Shaw J; Hickman M
    Addiction; 2017 Aug; 112(8):1408-1418. PubMed ID: 28160345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural barriers in the context of opiate substitution treatment in Germany--a survey among physicians in primary care.
    Schulte B; Schmidt CS; Kuhnigk O; Schäfer I; Fischer B; Wedemeyer H; Reimer J
    Subst Abuse Treat Prev Policy; 2013 Jul; 8():26. PubMed ID: 23875627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death from liver disease in a cohort of injecting opioid users in a Swedish city in relation to registration for opioid substitution therapy.
    Jerkeman A; Håkansson A; Rylance R; Wagner P; Alanko Blomé M; Björkman P
    Drug Alcohol Rev; 2017 May; 36(3):424-431. PubMed ID: 27241955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
    Larney S; Zador D; Sindicich N; Dolan K
    Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.
    Favrod-Coune T; Baroudi M; Casillas A; Rieder JP; Gétaz L; Barro J; Gaspoz JM; Broers B; Wolff H
    Swiss Med Wkly; 2013; 143():w13898. PubMed ID: 24186493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to overcome hurdles in opiate substitution treatment? A qualitative study with general practitioners in Belgium.
    Fraeyman J; Symons L; Van Royen P; Van Hal G; Peremans L
    Eur J Gen Pract; 2016 Jun; 22(2):134-40. PubMed ID: 26799738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot feasibility randomised controlled trial of an adjunct brief social network intervention in opiate substitution treatment services.
    Day E; Copello A; Seddon JL; Christie M; Bamber D; Powell C; Bennett C; Akhtar S; George S; Ball A; Frew E; Goranitis I; Freemantle N
    BMC Psychiatry; 2018 Jan; 18(1):8. PubMed ID: 29334921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
    Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
    J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-based treatment for opioid dependent offenders: a pilot study.
    Brown R; Gassman M; Hetzel S; Berger L
    Am J Addict; 2013; 22(5):500-2. PubMed ID: 23952897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of dispensing fees on compliance with opioid substitution therapy: a mixed methods study.
    Shepherd A; Perrella B; Hattingh HL
    Subst Abuse Treat Prev Policy; 2014 Aug; 9():32. PubMed ID: 25108396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness.
    Deering DEA; Sheridan J; Sellman JD; Adamson SJ; Pooley S; Robertson R; Henderson C
    Addict Behav; 2011 Jun; 36(6):636-642. PubMed ID: 21276664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.